about
Nonallergic rhinitis with eosinophilia syndromeNonallergic rhinitis with eosinophilia syndrome and related disordersFactors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girlsThe role of epinephrine in the treatment of anaphylaxis.Diagnosis and management of anaphylaxisDRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to VancomycinClinical reactivity to insect stings.Experimental models for the evaluation of treatment of allergic rhinitis.Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients.A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis.Acute acalculous cholecystitis: an unusual presenting feature of Churg-Strauss vasculitisHodgkin's lymphoma presenting with markedly elevated IgE: a case report.The role of epigenetics in the developmental origins of allergic disease.Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge.Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.Effects of phthalates on the development and expression of allergic disease and asthma.Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitis.Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model.Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.Sweet syndrome with associated systemic inflammatory response syndrome: an ultimately fatal case.Metformin-associated lactic acidosis in a low risk patient.Factors that affect the allergic rhinitis response to ragweed allergen exposure.Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.Questions and answers about anaphylaxis. An information sheet for patients.A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.Deliberate ingestion of peanut as a suicide attempt.Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.Prevalence of allergic sensitization to Russian thistle in Kingston and the South-eastern Ontario catchment area; a retrospective chart review.Update on the prevalence of allergic sensitization to Russian thistle in South-eastern Ontario: retrospective chart review.Investigating Immune Gene Signatures in Peripheral Blood from Subjects with Allergic Rhinitis Undergoing Nasal Allergen Challenge.Hemopneumothorax in a COPD patient treated with noninvasive positive pressure ventilation: the risk of attendant anticoagulation.Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit.Impact on quality of life during an allergen challenge research trial.Repeatability of nasal allergen challenge results - further validation of the allergic rhinitis clinical investigator collaborative (AR-CIC) protocols.Lack of effect of Grastek® on birch pollen-induced allergic rhinoconjunctivitis in the Environmental Exposure Unit.Administering multiple cumulative allergen challenges: An alternative nasal allergen challenge protocol for the Allergic Rhinitis-Clinical Investigator Collaborative.
P50
Q28196302-C684E6D6-9781-454E-A6B7-6250627FA96DQ28212052-DD205830-4174-413F-B7DB-B7025E5021B4Q33992093-30EE55B2-F2D2-4823-8232-6C9D2E442D23Q35051163-4AE08884-80FF-4BB1-B163-879B0CEC0800Q35202356-F69FF155-1B7C-4855-B96D-6C7AEAAA25A6Q35416250-5B72CD3A-789C-494A-9359-17C9D60D9E5AQ36178080-F6A279D7-737D-4442-890E-9529EA8D70B8Q36405243-BFD314DB-1CDC-4D28-944D-FF3C081FF665Q36709165-8D31334E-9790-4005-82C4-D15C34E19052Q36847148-22B92E55-0F6E-4187-B0FB-4B5F4ABDB79FQ36992718-E03ADC36-6CA1-4324-8B70-E9364F358BDEQ37479664-DF5A106D-024C-41D4-A5A7-905046B218DBQ37870460-1C0A3B18-D7FF-495A-924B-850755746D46Q38152491-15A17189-0C90-4547-9139-D59C62B6162BQ38180216-647A68FE-A3EC-4E27-AB63-834CDF5B4A17Q38204048-9D1DCDEF-3D87-44E9-8D7C-BDB7D1D2362BQ38765929-26AA6AF8-6924-4D5A-B65F-7D75ED84F281Q39224205-B4966883-8086-4292-BD53-8D78D2CFB602Q39359592-2B4333D3-21C3-477F-AAC1-4364C1FC417FQ39419178-C346BAA2-CCB2-4065-8DE0-CA970A92560AQ39431983-E4D15EF5-36AA-43B7-9701-7E298A67C5D4Q39453864-07758BF3-C4A0-4B8C-B417-3E456A7F97D6Q42863606-F94CDC16-819D-4366-8A68-8A20E7B763D4Q43700392-E84A07DE-26AA-4484-BB95-344BE12A9A0AQ43777621-DED478DA-CC2D-4654-BDB0-DAA1A6A593DBQ44201032-F9031BA5-479A-4ACE-ABDF-6AC7B5EF9CE7Q44568303-F3F378FD-0F21-48E0-BE20-763C5AA3CD6AQ44634862-7724B490-FD84-48F3-B5DF-791E5DFC9EEEQ45160327-71E126F8-000F-4EFD-B809-263A554729EFQ45956613-418DAF5B-DCCF-49E2-AE41-385C140C56C1Q46034544-A043DB2C-F84B-403E-AFDF-E99307B9C8EAQ46089060-7DB12502-929A-483D-99D2-5763A77251CBQ47739919-1828E451-C563-4A3D-A1BE-05FA1E05C446Q48001399-0D2A98CF-EC88-41E5-B2C5-0D640B7249BFQ48168829-F20E92E0-2C54-4CF9-9FDE-2C04A96D79CAQ48325641-FC55C561-611D-4A3C-8A53-3A72E6B8FB1EQ48750577-AF8ECE8B-C73B-4AFC-ABF5-4D48172786C5Q50046881-16EE48FB-B52A-4078-96B5-62A8D777F15EQ50060031-E36D5764-977A-487D-B086-8CFFEED795E7Q51457912-CFA3A181-3313-4A89-ACB3-29751ABEB1FA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne K Ellis
@ast
Anne K Ellis
@en
Anne K Ellis
@es
Anne K Ellis
@nl
type
label
Anne K Ellis
@ast
Anne K Ellis
@en
Anne K Ellis
@es
Anne K Ellis
@nl
prefLabel
Anne K Ellis
@ast
Anne K Ellis
@en
Anne K Ellis
@es
Anne K Ellis
@nl
P106
P21
P31
P496
0000-0002-0725-2353